Skip to content
2000
Volume 21, Issue 3
  • ISSN: 1389-5575
  • E-ISSN: 1875-5607

Abstract

Coronavirus disease 2019 (COVID-19), caused by severe acute respiratory syndromerelated coronavirus-2 (SARS-CoV-2), has become an ongoing pandemic worldwide. However, there are no vaccines or antiviral drugs with proven clinical efficacy. Therefore, a remedial measure is urgently needed to combat the devastating COVID-19. The pharmacological activities of Nacetylcysteine (NAC) and its potential functions in inhibiting the progression of COVID-19 make it a promising therapeutic agent for the infection. In this mini-review, we discussed the therapeutic potential of NAC in COVID-19 from the perspective of its multisite pharmacological actions.

Loading

Article metrics loading...

/content/journals/mrmc/10.2174/1389557520666201027160833
2021-02-01
2025-06-27
Loading full text...

Full text loading...

/content/journals/mrmc/10.2174/1389557520666201027160833
Loading
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error
Please enter a valid_number test